XNAS · NAGE
-12.97% · -$0.4500 · Vol 1.8M
After hours · updated 18:19:24 ET
Niagen Bioscience, Inc. Common Stock

Niagen Bioscience, Inc. Common Stock

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
$3.02
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
NAGE
Niagen Bioscience, Inc. Common Stock
Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

76/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is NAGE moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading NAGE catalysts
About Niagen Bioscience, Inc. Common Stock
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Listed since
2008
Employees
117
Country
US

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.11
Day high
$3.21
Day low
$2.87
Previous close
$3.47
52W high
$10.26
-70.57% from high
52W low
$2.87
2% of range
Market cap
$276.4M
P/E
13.73×
EPS
$0.2200
Beta
1.41
Shares out
79.6M
Volume
1.8M
2.27× rel vol
Avg volume
805K
VWAP
$3.04
Price history computed in-house
1W
-6.21%
1M
-13.71%
3M
-27.92%
1Y
-67.03%
YTD
-52.52%
SMA 50 $3.43 · below
SMA 200 $5.11 · below
52W position 2%

NAGE overview

Veridion Score
76
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around NAGE.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading NAGE Form 4 filings
Public disclosures

Congress activity in NAGE

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for NAGE in the cached public ledger.

Federal contracts

NAGE contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NAGE in this window.
Lobbying spend

NAGE lobbying filings, year to date.

Registered lobbying filings matched to Niagen Bioscience, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NAGE in this window.
Loading news for NAGE
Analyst ratings
Sovereign unlock shows live analyst consensus for NAGE.
Options
Sovereign unlock shows live options positioning for NAGE.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.